These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24918581)

  • 21. Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells.
    Vazquez-Martin A; Cufí S; López-Bonet E; Corominas-Faja B; Cuyàs E; Vellon L; Iglesias JM; Leis O; Martín AG; Menendez JA
    Cell Cycle; 2013 Nov; 12(22):3471-7. PubMed ID: 24107627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The T-box transcription factor Brachyury regulates epithelial-mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cells.
    Shimoda M; Sugiura T; Imajyo I; Ishii K; Chigita S; Seki K; Kobayashi Y; Shirasuna K
    BMC Cancer; 2012 Aug; 12():377. PubMed ID: 22931165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-155 promotes the proliferation and invasion abilities of colon cancer cells by targeting quaking.
    He B; Gao SQ; Huang LD; Huang YH; Zhang QY; Zhou MT; Shi HQ; Song QT; Shan YF
    Mol Med Rep; 2015 Mar; 11(3):2355-9. PubMed ID: 25420938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation.
    Berezovsky AD; Poisson LM; Cherba D; Webb CP; Transou AD; Lemke NW; Hong X; Hasselbach LA; Irtenkauf SM; Mikkelsen T; deCarvalho AC
    Neoplasia; 2014 Mar; 16(3):193-206, 206.e19-25. PubMed ID: 24726753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NONO Is a Negative Regulator of
    Liang S; Takahashi H; Hirose T; Kuramitsu Y; Hatakeyama S; Yoshiyama H; Wang R; Hamada JI; Iizasa H
    Cancer Genomics Proteomics; 2020; 17(4):359-367. PubMed ID: 32576581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
    Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
    J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth.
    Kim EJ; Kim JS; Lee S; Lee H; Yoon JS; Hong JH; Chun SH; Sun S; Won HS; Hong SA; Kang K; Jo JY; Choi M; Shin DH; Ahn YH; Ko YH
    Int J Cancer; 2019 Sep; 145(6):1585-1595. PubMed ID: 31026342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity.
    Nakatsugawa M; Takahashi A; Hirohashi Y; Torigoe T; Inoda S; Murase M; Asanuma H; Tamura Y; Morita R; Michifuri Y; Kondo T; Hasegawa T; Takahashi H; Sato N
    Lab Invest; 2011 Dec; 91(12):1796-804. PubMed ID: 21931300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma.
    Li J; Li Z; Wu Y; Wang Y; Wang D; Zhang W; Yuan H; Ye J; Song X; Yang J; Jiang H; Cheng J
    Cell Death Dis; 2019 Aug; 10(8):603. PubMed ID: 31399556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.
    Corominas-Faja B; Cufí S; Oliveras-Ferraros C; Cuyàs E; López-Bonet E; Lupu R; Alarcón T; Vellon L; Iglesias JM; Leis O; Martín ÁG; Vazquez-Martin A; Menendez JA
    Cell Cycle; 2013 Sep; 12(18):3109-24. PubMed ID: 23974095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
    Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC
    Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced O-GlcNAc modification induced by the RAS/MAPK/CDK1 pathway is required for SOX2 protein expression and generation of cancer stem cells.
    Shimizu M; Shibuya H; Tanaka N
    Sci Rep; 2022 Feb; 12(1):2910. PubMed ID: 35190631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway.
    Han B; Wang R; Chen Y; Meng X; Wu P; Li Z; Duan C; Li Q; Li Y; Zhao S; Jiang C; Cai J
    Cell Oncol (Dordr); 2019 Dec; 42(6):801-813. PubMed ID: 31292920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-214 regulates smooth muscle cell differentiation from stem cells by targeting RNA-binding protein QKI.
    Wu Y; Li Z; Yang M; Dai B; Hu F; Yang F; Zhu J; Chen T; Zhang L
    Oncotarget; 2017 Mar; 8(12):19866-19878. PubMed ID: 28186995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SOX2 promotes a cancer stem cell-like phenotype and local spreading in oral squamous cell carcinoma.
    Sacco A; Battaglia AM; Santamaria G; Buffone C; Barone S; Procopio A; Lavecchia AM; Aversa I; Giorgio E; Petriaggi L; Cristofaro MG; Biamonte F; Giudice A
    PLoS One; 2023; 18(12):e0293475. PubMed ID: 38096163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spheroid body-forming cells in the human gastric cancer cell line MKN-45 possess cancer stem cell properties.
    Liu J; Ma L; Xu J; Liu C; Zhang J; Liu J; Chen R; Zhou Y
    Int J Oncol; 2013 Feb; 42(2):453-9. PubMed ID: 23229446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MSX2 represses tumor stem cell phenotypes within oral squamous cell carcinomas via SOX2 degradation.
    Keyimu R; Tuerdi M; Zhao Z
    Exp Biol Med (Maywood); 2021 Dec; 246(24):2660-2670. PubMed ID: 34435915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The FBXW2-MSX2-SOX2 axis regulates stem cell property and drug resistance of cancer cells.
    Yin Y; Xie CM; Li H; Tan M; Chen G; Schiff R; Xiong X; Sun Y
    Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20528-20538. PubMed ID: 31548378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis.
    Michifuri Y; Hirohashi Y; Torigoe T; Miyazaki A; Kobayashi J; Sasaki T; Fujino J; Asanuma H; Tamura Y; Nakamori K; Hasegawa T; Hiratsuka H; Sato N
    Pathol Int; 2012 Oct; 62(10):684-9. PubMed ID: 23005595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated expression of JMJD6 is associated with oral carcinogenesis and maintains cancer stemness properties.
    Lee CR; Lee SH; Rigas NK; Kim RH; Kang MK; Park NH; Shin KH
    Carcinogenesis; 2016 Feb; 37(2):119-128. PubMed ID: 26645717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.